Bank of America Spends Over $250 Million Annually on GLP-1 Drugs
Bank of America's CEO has revealed that the company spends more than $250 million annually on GLP-1 drugs for its employees. This significant expenditure highlights the growing use of these medications within corporate health benefits.
The Story
Analyzing sources…
Source Diversity
Source Diversity
Low (19/100)Sources
Bank of America spends $250 million a year on GLP-1 drugs for its employees, CEO says
Employers have grappled with soaring demand for GLP-1 drugs such as Ozempic and Wegovy, which can cost thousands of dollars per patient annually.
Read full article →Bank of America spends more than $250 million on GLP-1s
Brian Moynihan said Bank of America spends more than $250,000 on GLP-1s. Bloomberg/Getty Images Bank of America spends more than $250 million on GLP-1s for its employees. CEO Brian Moynihan said it's part of a long-term investment in employee health. GLP-1s are not only transforming corporate healthcare budgets, but also introducing HR nightmares. Weight-loss drugs are costing Bank of America more than a quarter of a million dollars a year. CEO Brian Moynihan said that the more than $250 mi...
Read full article →